Viewing Study NCT00274820

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:14 AM
Ignite Modification Date: 2026-01-25 @ 12:53 AM
Study NCT ID: NCT00274820
Status: COMPLETED
Last Update Posted: 2020-07-27
First Post: 2006-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Myelofibrosis/Myeloproliferative Disorder
Sponsor: Case Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Myeloproliferative Disorders View
None Leukemia View
None Myelodysplastic Syndromes View
None Myelodysplastic/Myeloproliferative Diseases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic idiopathic myelofibrosis View
None chronic myelomonocytic leukemia View
None atypical chronic myeloid leukemia View
None myelodysplastic/myeloproliferative disease, unclassifiable View
None de novo myelodysplastic syndromes View
None previously treated myelodysplastic syndromes View
None secondary myelodysplastic syndromes View